🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06125392
Recruiting Observational

Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition

NCT06125392 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-09-30
Last updated
2024-11-01

Condition(s) studied

Coronary Microvascular DiseaseCoronary Vasospasm

Investigational drug(s) / intervention(s)

Coronary physiology assessment

Coronary physiology assessment: Resting distal coronary to aortic pressure ratio, resting flow ratio, fractional flow reserve, Coronary Flow Reserve and Microvascular resistance using the thermodilution method and papaverin or adenosine, Resting distal coronary to aortic pressure ratio, resting flow ratio, fractional flow reserve, Coronary Flow Reserve and Microvascular resistance using the thermodilution method and acetylcholine.

Study summary

The MICRO-SNAPE registry will collect data from patients undergoing investigation of microvascular dysfunction and coronary spasm in Europe and North America.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who underwent combined measurements of coronary pressure and flow in at least 1 native coronary artery in response to endothelium dependent and independent vasodilators. Exclusion Criteria: * Hemodynamic instability * Age \<18 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Center of Cardiology, Cardiology I, university hospital Mainz Mainz Rhineland-Palatinate Recruiting

More Johannes Gutenberg University Mainz trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06125392 on ClinicalTrials.gov ↗ ← All trials in Germany